Cargando…

A potential link between endothelial function, cardiovascular risk, and metabolic syndrome in patients with Non-alcoholic fatty liver disease

BACKGROUND: Asymmetric dimethylarginine (ADMA) is an endogenous competitive inhibitor of nitric oxide (NO) synthetase. Elevated ADMA reduces NO formation and is associated with endothelial dysfunction. The aims of this study were to evaluate endothelial function and the cardiovascular risk (CVR) pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sayki Arslan, Muyesser, Turhan, Sibel, Dincer, Irem, Mizrak, Dilsa, Corapcioglu, Demet, Idilman, Ramazan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2014
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4424578/ https://www.ncbi.nlm.nih.gov/pubmed/25960770 http://dx.doi.org/10.1186/1758-5996-6-109

Ejemplares similares

Determining Subclinical Cardiovascular and Cardiac Diseases in Patients with Non-Alcoholic Fatty Liver Disease
por: Karaoğlan, Beliz Bahar, et al.
Publicado: (2023)

The natural course of non-alcoholic fatty liver disease
por: Seval, Guldane Cengiz, et al.
Publicado: (2020)

The role of PNPLA3 (rs738409) c>g variant on histological progression of non-alcoholic fatty liver disease
por: Idilman, Ramazan, et al.
Publicado: (2020)

Frequency of nodular goiter and autoimmune thyroid disease and association of these disorders with insulin resistance in polycystic ovary syndrome
por: Karaköse, Melia, et al.
Publicado: (2017)

Lobectomy may not be suitable for patients with follicular neoplasm cytology
por: UÇAN, Bekir, et al.
Publicado: (2020)

Copeptin, a surrogate marker for arginine vasopressin, is associated with cardiovascular risk in patients with polycystic ovary syndrome
por: Karbek, Basak, et al.
Publicado: (2014)

Non-alcoholic fatty liver disease may be associated with endothelial dysfunction
por: Balta, Sevket, et al.
Publicado: (2014)

Osteogenesis Imperfecta, Pseudoachalasia, and Gastric Cancer
por: Mizrak, Dilsa, et al.
Publicado: (2015)

Recent advances in preoperative management of esophageal adenocarcinoma
por: Harada, Kazuto, et al.
Publicado: (2017)

The role of magnetic resonance elastography in the evaluation of nonalcoholic fatty liver disease
por: Idilman, Ilkay S., et al.
Publicado: (2023)

Non-Alcoholic Fatty Liver Disease and Cardiovascular Comorbidities: Pathophysiological Links, Diagnosis, and Therapeutic Management
por: Jichitu, Alexandra, et al.
Publicado: (2021)

Role of cytological characteristics of benign thyroid nodules on effectiveness of their treatment with levothyroxine
por: Cesur, Mustafa, et al.
Publicado: (2013)

Non-alcoholic fatty liver disease and cardiovascular risk
por: Patil, Rashmee, et al.
Publicado: (2017)

Solitary Fibrous Tumor of Neck Mimicking Cold Thyroid Nodule in 99m Tc Thyroid Scintigraphy
por: Topaloglu, Oya, et al.
Publicado: (2013)

The relationship between LH and thyroid volume in patients with PCOS
por: Cakir, Evrim, et al.
Publicado: (2012)

Isolated Vitamin D Deficiency Is Not Associated with Nonthyroidal Illness Syndrome, but with Thyroid Autoimmunity
por: Sayki Arslan, Muyesser, et al.
Publicado: (2015)

Association between Visceral Adipose Tissue and Non-Alcoholic Steatohepatitis Histology in Patients with Known or Suspected Non-Alcoholic Fatty Liver Disease
por: Idilman, Ilkay S., et al.
Publicado: (2021)

Immunoglobulin light chain amyloidosis presenting as Budd-Chiari syndrome
por: Ozercan, Mubin, et al.
Publicado: (2021)

Relationship Between Vitamin D Levels and β Cell Function and Insulin Resistance
por: Ozcan, Cem, et al.
Publicado: (2023)

1150 The Disease Burden of Chronic Hepatitis C in Turkey
por: Idilman, Ramazan
Publicado: (2014)

Customization of therapy for gastroesophageal adenocarcinoma patients
por: Mizrak Kaya, Dilsa, et al.
Publicado: (2018)

Hepatokines and Non-Alcoholic Fatty Liver Disease: Linking Liver Pathophysiology to Metabolism
por: Kim, Tae Hyun, et al.
Publicado: (2021)

Cardiovascular disease in patients with non-alcoholic fatty liver disease
por: Kantartzis, Konstantinos, et al.
Publicado: (2012)

Endothelial dysfunction and carotid atherosclerosis in non-alcoholic fatty liver disease
por: Dogru, Teoman, et al.
Publicado: (2014)

Study of Endothelial Dysfunction in Patients With Non-alcoholic Fatty Liver Disease
por: Jose, Nijin, et al.
Publicado: (2021)

NSAID-associated drug-induced liver injury prior to and following liver transplantation
por: Gumussoy, Mesut, et al.
Publicado: (2022)

Relationship between non-alcoholic fatty liver disease and coronary heart disease
por: Arslan, Ugur, et al.
Publicado: (2020)

Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?
por: Chandrasekharan, Karthik, et al.
Publicado: (2020)

Pathophysiological mechanisms of cardiovascular disorders in non-alcoholic fatty liver disease
por: Garbuzenko, Dmitry Victorovich
Publicado: (2022)

Cardiovascular Risk Induced by the Presence of Non-alcoholic Fatty Liver Disease
por: Dascalu, Daciana
Publicado: (2023)

Liver fibrosis and its response to avapritinib in 2 patients with systemic mastocytosis
por: Cavazos, Karla, et al.
Publicado: (2022)

Free Fatty Acids Differentially Downregulate Chemokines in Liver Sinusoidal Endothelial Cells: Insights into Non-Alcoholic Fatty Liver Disease
por: McMahan, Rachel H., et al.
Publicado: (2016)

The prevalence of metabolic-associated fatty liver disease in the Turkish population: A multicenter study
por: Yilmaz, Yusuf, et al.
Publicado: (2021)

Molecular links between non-alcoholic fatty liver disease and hepatocellular carcinoma
por: Raza, Sana, et al.
Publicado: (2019)

Hepatic Unsaturated Fatty Acids Are Linked to Lower Degree of Fibrosis in Non-alcoholic Fatty Liver Disease
por: Fridén, Michael, et al.
Publicado: (2022)

Serum levels of vascular endothelial growth factor in non-alcoholic fatty liver disease
por: Papageorgiou, Maria-Vasiliki, et al.
Publicado: (2017)

Association of non-alcoholic fatty liver disease with cardiovascular disease and subclinical atherosclerosis
por: Sao, Rahul, et al.
Publicado: (2017)

The Association between Non-Alcoholic Fatty Liver Disease and Cardiovascular Risk in Children
por: Di Sessa, Anna, et al.
Publicado: (2017)

Assessment of Genetic Aspects of Non-alcoholic Fatty Liver and Premature Cardiovascular Events
por: Saki, Sara, et al.
Publicado: (2020)

Cardiovascular Risk in Non-Alcoholic Fatty Liver Disease: Mechanisms and Therapeutic Implications
por: Tana, Claudio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_fr1gbgv5fecqvrlik8a138poaj